vimarsana.com
Home
Live Updates
Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript : vimarsana.com
Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript : vimarsana.com
Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript
Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.
Related Keywords
United States ,
America ,
Cristi Barnett ,
Samantha Semenkow ,
Brian Cheng ,
Erick Lucera ,
Joon Lee ,
Baisong Mei ,
Gilmore Oneill ,
Caren Deardorf ,
Greg Harrison ,
Linda Burkly ,
Editas Medicine Inc ,
Nasdaq ,
Corporate Communications ,
Vertex Pharmaceuticals ,
Most Valuable Electric Car Companies ,
Editas Medicine ,
Call Transcript February ,
Fourth Quarter ,
Full Year ,
Investor Relations ,
Safe Harbor ,
Private Securities Litigation Reform Act ,
Risk Factors ,
Annual Report ,
Chief Medical Officer ,
Chief Financial Officer ,
Chief Scientific Officer ,
Chief Commercial ,
Strategy Officer ,
Chief Medical ,
Chief Financial ,
Valuable Electric Car Companies ,
Whati Ll ,